White Paper

Steps To Successfully Complete An FDA Inspection

By James Jardine

GettyImages-627646012-planning-collaboration

For many manufacturers, facility inspections by the U.S. Food and Drug Administration (FDA) can be very difficult, and findings over the course of an inspection can have significant consequences. Depending on the severity of the findings and the manufacturer’s response to findings, the agency can issue warning letters, consent decrees or fines and initiate injunctions, seizures and criminal prosecution.

With proper preparation, however, the FDA’s call to schedule an inspection doesn’t have to be a nightmare scenario. This white paper identifies key steps that manufacturers, life science companies and other organizations operating in FDA-regulated environments should take before, during and after an FDA inspection to ensure a successful audit.

VIEW THE WHITE PAPER!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online